Agree to disagree, but I appreciate the civil response.
I'm here because Prolanta received ODD designation and the initial science behind appears promising.
To demonstrate that science, the company has to run a Phase I trial (and then Phase II, Phase III, etc. if things go right), and that costs money.
If the science works, then debt, etc. will affect overall return but we will all make money (with when and how much TBD) buying at these levels.
Time will tell if I'm right.
Either way, GLTA!